Examination Report |
1 | Reply to Exam Report (MIS-R) | 05 Mar 2009 |
10 | Other Documents | 12 Nov 2012 |
11 | Covering Letter | 14 Nov 2012 |
12 | Refusal Notice | 14 Nov 2012 |
13 | Hearing Notice | 15 Nov 2013 |
14 | Note Sheet | 19 May 2014 |
15 | Note Sheet | 19 May 2014 |
16 | Hearing Notice | 19 May 2014 |
17 | Note Sheet | 19 May 2014 |
2 | Note Sheet | 05 Mar 2009 |
3 | TM-1 | 05 Mar 2009 |
4 | Additional Representation Sheet | 05 Mar 2009 |
5 | Examination Report | 18 Jun 2010 |
6 | TM-56 | 28 Jul 2011 |
7 | Affidavit | 16 Nov 2011 |
8 | Correspondence | 16 Nov 2011 |
9 | TM-15 | 31 Jul 2012 |
The application for Oflazen was made on 05 March 2009.
The trademark applicant for Oflazen is BAL PHARMA.
Oflazen is applied in class(es) 5.
Application for Oflazen is on Refused stage.
Application Id allotted to Oflazen is 1792593.
Oflazen filed with the Intellectual property office as a WORD.